pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$DAREDare Bioscience, Inc.

$DARE
San Diego, CA, USupdated 4mo ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
5
marketed
2
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(5)

pipeline depth5 products
Preclinical: 1Phase 1: 1Phase 2: 1Marketed: 2
1Preclinical1Phase 11Phase 22Marketed
Marketed
(estradiol + progesterone)
Genitourinary Syndrome of Menopause (GSM)
Marketed
etonogestrel CR
Female Contraception
Phase 2
sildenafil citrate
Female Hypoactive Sexual Desire Disorder
cGMP-specific 3',5'-cyclic phosphodiesterase
Phase 1
(lopinavir + ritonavir)
Cervical Intraepithelial Neoplasia (CIN)
Preclinical
levonorgestrel LA
Female Contraception

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Dare Bioscience, Inc. jobs →

News

  • Opinion: The most shocking thing about the latest statistics on CTE in football is that we find them so shocking
    The latest study on CTE in football players “quantifies but does not reveal a problem,” writes Emily Harrison, a historian who studies brain injury in football.
    stat · 1mo ago
  • STAT+: The moment Anthropic convinced me it’s serious about science
    AI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.
    stat · 3mo ago
  • Nonprofit buys experimental cancer drug to maintain patient access
    In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug.
    stat · 3mo ago
  • STAT+: An insider reveals the real goals of prior authorization
    Years ago, Archelle Georgiou helped squash prior auths at one of America's biggest health insurers.
    stat · 5mo ago
identifiers
ticker
$DARE
SEC CIK
0001401914
country
US
source
sec_tickers
top tags
Women's Health2
mentioned in
4news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 7m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?